Table 3.
Antileishmanial activity of 1–18
| Compound | IC50 (μM) | IC90 (μM) |
|---|---|---|
| 1 | 40.7 | NA |
| 2 | 87.9 | NA |
| 3 | 30.0 | NA |
| 4 | 7.4 | 38.5 |
| 5 | 12.8 | 47.9 |
| 6 | 5.9 | 32.7 |
| 7 | 24.9 | 62.3 |
| 8 | NA | NA |
| 9 | 20.9 | 62.8 |
| 10 | 2.5 | 9.4 |
| 11 | 6.0 | 22.9 |
| 12 | 6.4 | 29.7 |
| 13 | 3.9 | 47.1 |
| 14 | 22.8 | 55.5 |
| 15 | 25.8 | 112.2 |
| 16 | 5.7 | 24.6 |
| 17 | 42.3 | NA |
| 18 | 5.0 | 44.2 |
| pentamidinea | 2.8 | 6.4 |
| amphotericin Ba | 0.2 | 0.4 |
IC50: concentration causing 50% growth inhibition. IC90: concentration causing 90% growth inhibition.
NA: not active.
Control.